FTC & anthrax
This article was originally published in The Tan Sheet
Executive Summary
Twenty-three of approximately 50 Web sites contacted by commission for falsely marketing products as anthrax remedies have complied and stopped marketing challenged items as of Dec. 14, with two more expected to comply by Dec. 17, FTC says. Commission sent additional 10 letters to questionable sites after initial wave of 40 letters (1"The Tan Sheet" Nov. 26, p. 17). More letters planned for firms marketing test kits, gas masks, FTC says...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.